Showing 581-590 of 2676 results for "".
Dementia Insights: What Do Animal Models of Alzheimer’s Disease Tell Us?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-what-do-animal-models-ofalzheimers-disease-tell-us/31560/Understanding pathologic mechanisms provides test beds for finding treatments.The Evolving Role of Neurologists Amid the Endovascular Revolution in Stroke Care
https://practicalneurology.com/diseases-diagnoses/stroke/the-evolving-role-of-neurologists-amid-the-endovascular-revolution-in-stroke-care/30391/New standards of care are shaping a brighter future in stroke treatment, but many challenges remain.Emerging Therapies for Progressive Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/emerging-therapies-for-progressive-multiple-sclerosis/30125/A number of agents with putative neuroprotective effects have shown promise in recent clinical trials.Update in Epilepsy Therapeutics
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/update-in-epilepsy-therapeutics/30511/In addition to comorbid conditions and side effects, cost and availability should factor into therapeutic selection.Opportunities for Patients Arising From Practicalities of Health Care
https://practicalneurology.com/archives/2018-feb/opportunities-for-patients-arising-from-practicalities-of-health-care/30273/Telepresence in Neurology
https://practicalneurology.com/columns/practice-management/telepresence-in-neurology/30389/Multiple Sclerosis: In-Focus
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-focus/30519/Delayed MS Drugs Awaits Decision at FDA
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/delayed-ms-drugs-awaits-decision-at-fda/30657/Pain and Gain: Reassessing Hydrocodone Prescribing
https://practicalneurology.com/diseases-diagnoses/headache-pain/pain-and-gain-reassessing-hydrocodone-prescribing/30742/New recommendations by an FDA committee aim to decrease opioid abuse, the group says, but will physicians and patients bear the burden of its effects?Letter to the Editor: At Face Value: Obama and Neurology
https://practicalneurology.com/columns/practice-management/1109_06-php/30875/